Since the tumor microenvironment, particularly the inflammatory response, may play an important role in cancer development and progression, it has been suggested that measuring clinical factors involved in inflammation, such as CRP, albumin, and white blood cells, may predict systemic cancer progression and metastasis [20]. The gene discussed is ALB; the disease is cancer.